REGULATED PRESS RELEASE published on 02/18/2026 at 07:00, 7 months 19 days ago bioMérieux launches SMARTBIOME™ to help food manufacturers gain deeper insights into spoilage and protect product quality bioMérieux launches SMARTBIOME™, an innovative solution combining DNA sequencing, bioinformatics, and microbiology expertise to help food manufacturers understand, control, and prevent spoilage, improving product quality and consumer safety BioMérieux DNA Sequencing SMARTBIOME™ Food Manufacturers Microbiological Spoilage
BRIEF published on 02/04/2026 at 11:56, 8 months 4 days ago BioMérieux: Statement on Capital and Voting Rights Share Capital Voting Rights Shares BioMérieux Finances
BRIEF published on 01/22/2026 at 08:34, 8 months 18 days ago BioMérieux Acquires Accellix to Enhance Quality Control in Advanced Therapies Acquisition BioMérieux Cell And Gene Therapy Quality Control Accellix
REGULATED PRESS RELEASE published on 01/22/2026 at 08:29, 8 months 18 days ago bioMérieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies bioMérieux acquires Accellix to enhance pharmaceutical quality control and support advanced therapies, bolstering innovation and patient outcomes globally Acquisition BioMérieux Advanced Therapies Accellix Pharmaceutical Quality Control
BRIEF published on 01/07/2026 at 15:44, 9 months 1 day ago BioMérieux: Update on capital and voting rights Share Capital Voting Rights BioMérieux Actions Financial Regulations
BRIEF published on 12/04/2025 at 07:06, 10 months 5 days ago BioMérieux Introduces Equine Endocrinology Testing for Enhanced Horse Health Veterinary Diagnostics Point Of Care Equine Health Endocrinology Tests BioMérieux Innovation
REGULATED PRESS RELEASE published on 12/04/2025 at 07:01, 10 months 5 days ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health bioMérieux launches endocrinology testing offer for equine health with VIDAS® Equine ACTH and INSULIN immunoassays BioMérieux Veterinary Medicine Endocrinology Equine Health Immunoassay Tests
BRIEF published on 12/02/2025 at 15:49, 10 months 6 days ago BioMérieux: Update on the number of shares and voting rights Share Capital Voting Rights BioMérieux Actions Finance
BRIEF published on 11/05/2025 at 07:06, 11 months 4 days ago Oxford Nanopore and bioMérieux Unveil AmPORE-TB for Drug-Resistant TB Analysis BioMérieux Tuberculosis AmPORE-TB Oxford Nanopore Sequencing Technology
REGULATED PRESS RELEASE published on 11/05/2025 at 07:01, 11 months 4 days ago Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only solution for rapid characterization of drug resistant-tuberculosis, using nanopore sequencing technology BioMérieux AmPORE-TB Oxford Nanopore Sequencing Technology Drug-resistant Tuberculosis
Published on 10/09/2026 at 08:00, 2 hours 16 minutes ago Caledonia Mining Corporation Blanket Mine Q3 Production Update and Revised Guidance for 2026
Published on 10/08/2026 at 22:05, 12 hours 11 minutes ago Rochon Family Executes Additional Strategic Purchase of $26.8 Million of AIAI Holdings Shares
Published on 10/08/2026 at 20:30, 13 hours 46 minutes ago Guanajuato Silver Completes San Ignacio to Bolanitos Connection Tunnel
Published on 10/08/2026 at 14:31, 19 hours 45 minutes ago First Breach Expands Hiring Initiative to Support Ammunition Production Growth and Planned Drone Manufacturing Operations
Published on 10/08/2026 at 14:30, 19 hours 46 minutes ago Predictiv AI's Shift AI Completes AWS Foundational Technical Review and Expands Aviation Visibility Through AWS Solutions Library
Published on 10/09/2026 at 09:01, 1 hour 14 minutes ago NAGA SECURES USD 8 MILLION STRATEGIC INVESTMENT AND NEW EXPERTISE TO ACCELERATE PROFITABLE GROWTH
Published on 10/09/2026 at 09:00, 1 hour 16 minutes ago Original-Research: HausVorteil AG (von NuWays AG): BUY
Published on 10/09/2026 at 09:00, 1 hour 16 minutes ago Original-Research: Verbio SE (von NuWays AG): BUY
Published on 10/09/2026 at 09:00, 1 hour 16 minutes ago Original-Research: Nexstim Oyj (von NuWays AG): BUY
Published on 10/09/2026 at 09:00, 1 hour 16 minutes ago Original-Research: MHP Hotel AG (von NuWays AG): BUY
Published on 10/08/2026 at 18:30, 15 hours 46 minutes ago Cegedim: Release of its 2026 Interim Financial Report
Published on 10/08/2026 at 18:00, 16 hours 16 minutes ago Launch of LINK, the next generation of THIN: Clinityx’s first European Health Data Warehouse, approved by the French Data Protection Authority for 10 years
Published on 10/08/2026 at 17:45, 16 hours 31 minutes ago Carrefour announces a real estate sale and leaseback transaction involving 35 stores in France and Spain
Published on 10/07/2026 at 18:19, 1 day 15 hours ago Outstanding shares and voting rights statement at 30 September 2026